+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Osteoprotegerin in cardiovascular disease: ally or enemy?



Osteoprotegerin in cardiovascular disease: ally or enemy?



Current Pharmaceutical Design 20(37): 5862-5869



The OPG/RANK/RANKL axis is now recognized as a master regulator of bone remodeling, controlling osteoclast's maturation and extracellular matrix calcification. Nevertheless, a number of clinical and basic science studies conducted in the last few years demonstrated that the triad could be also involved in several physiological and pathological processes outside the bone tissue. In particular, evidences have been collected showing an active participation of OPG and RANKL in vascular pathology, including atherogenesis and arterial calcification. A series of epidemiological studies also showed that increased circulating levels of OPG are associated with significant, independent predictive value for future cardiovascular mortality/morbidity. However, the human studies did not unravel whether OPG should be considered as a promoter, a protective mechanism or is instead neutral with regard of vascular disease progression. Main objective of the present review is to summarize findings from both in vivo and in vitro investigations on the role played by OPG in vascular disease progression and to delineate a plausible scenario on the actual involvement of the OPG/RANK/RANKL triad and TRAIL in cardiovascular pathology.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 054802343

Download citation: RISBibTeXText

PMID: 24533937


Related references

Ecology. The enemy of my enemy is my ally. Science 291(5511): 2104-2105, 2001

Eryptosis: Ally or Enemy. Current Medicinal Chemistry: -, 2016

Time: ally or enemy. Trends & Techniques in the Contemporary Dental Laboratory 4(4): 6, 12, 44-7, 1987

Bird enemy or ally?. 1977

Fire: an ally or an implacable enemy?. Boletim Informativo da Sociedade Brasileira de Ciencia do Solo 23(3): 20-33, 1998

Is obesity an enemy or ally to one's health?. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 84(8): 1213-1216, 1995

The enemy of my enemy is my ally. Science 291(5511): 04-5, 2001

Acidic pH: enemy or ally for enteric bacteria?. Virulence 3(2): 103-106, 2012

Intracellular parasitism: enemy turns ally. Proceedings of the Royal Institution of Great Britain, 58: 223-239, 1986

Pain in internal diseases: enemy or ally?. Polskie Archiwum Medycyny Wewnetrznej 70(4): 167-171, 1983

The nucleolus, an ally, and an enemy of cancer cells. Histochemistry and Cell Biology 150(6): 607-629, 2018

Probiotics: an obedient ally or an insidious enemy?. Critical Care 16(6): 456-456, 2015

Citrus tristeza virus: making an ally from an enemy. Annual Review of Phytopathology 53: 137-155, 2016

Forestland fire: industrys enemy and management ally. Proceedings ub 1976), 15 127-133, 1976

O-GlcNAcylation, enemy or ally during cardiac hypertrophy development?. Biochimica et Biophysica Acta 1862(12): 2232-2243, 2016